Daiichi Sankyo Company, Limited (DSNKY)
OTCMKTS · Delayed Price · Currency is USD
24.48
+0.13 (0.53%)
Aug 14, 2025, 1:44 PM EDT
Daiichi Sankyo Company Market Cap
Daiichi Sankyo Company has a market cap or net worth of $44.89 billion as of August 14, 2025. Its market cap has decreased by -38.04% in one year.
Market Cap
44.89B
Enterprise Value
42.36B
Revenue
13.34B
Ranking
n/a
PE Ratio
21.89
Stock Price
$24.48
Market Cap Chart
Since September 28, 2005, Daiichi Sankyo Company's market cap has increased from 2.93B to 44.89B, an increase of 1,434.10%. That is a compound annual growth rate of 14.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 45.06B | -13.60% |
| Dec 30, 2024 | 52.16B | -0.97% |
| Dec 29, 2023 | 52.67B | -14.75% |
| Dec 30, 2022 | 61.78B | 26.88% |
| Dec 30, 2021 | 48.69B | -26.63% |
| Dec 30, 2020 | 66.36B | 54.24% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 798.20M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 567.50M |
| Glass House Brands | 543.74M |
| Northwest Biotherapeutics | 349.08M |
| American Oncology Network | 337.45M |
| CytoDyn | 300.87M |